top of page

Occam Places Wildon Farwell as CMO of Dyne

Dyne Therapeutics, an Atlas Investment, is a platform biotech developing therapeutics across neuromuscular indications.

In early 2021, Occam recruited Wildon Farwell, MD as the company’s CMO. Previously, Wildon held a lengthy career at Biogen, having most recently served as the company’s Global Medical Head for Neuromuscular Diseases.

bottom of page